Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

University of Minnesota (UMN)

Status and phase: Completed; Phase 4

Conditions: Pain, Acute; Pain; Anesthesia

Treatments: Drug: Sublingual Sufentanil

Study type: Interventional

Funder types: Other

Identifiers

NCT04387136

ANES-2020-28605

Details and patient eligibility

About

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

Full description

This is a level I randomized prospective outcomes study comparing two groups of patients. Within 15-30 minutes of planned wake-up Group 1 will receive 30 mcg of sublingual sufentanil and group 2 will not receive sublingual sufentanil.

Enrollment: 53 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery

Exclusion criteria

• non-english speaking patients
• patients who have allergy or intolerance to the study drugs or derivatives

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

53 participants in 2 patient groups

Sublingual Sufentanil

Experimental group

Description:

Participants in this arm will receive the intervention.

Treatment:

Drug: Sublingual Sufentanil

Control

No Intervention group

Description:

Participants in this arm will not receive an intervention.